Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04098991 · ClinicalTrials.gov registry record
Improving White Matter Integrity With Thyroid Hormone
A clinical trial, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- 5
- Enrollment target
NCT04098991 is a clinical trial that has completed, run by University of Illinois at Chicago. The registered enrollment target is 5 participants.
The verdict
NCT04098991 has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
Animal studies have shown that thyroid hormone can improve white matter integrity after damage to myelin, which insulates and protects nerves. It is currently unknown whether this type of repair can occur in humans. The purpose of the proposed study is to examine the impact of thyroid hormone on white matter integrity in humans using two complementary, state-of-the-art neuroimaging techniques: high angular diffusion imaging and multicomponent relaxometry.
Interventions
- DRUG Levothyroxine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2017-11-08 |
| Est. Completion | 2019-11-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04098991
The ClinicalTrials.gov registry entry for NCT04098991 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Levothyroxine is the first listed.
NCT04098991 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04098991 about?
NCT04098991 is a clinical study titled "Improving White Matter Integrity With Thyroid Hormone". Animal studies have shown that thyroid hormone can improve white matter integrity after damage to myelin, which insulates and protects nerves. It is currently unknown whether this type of repair can occur in humans. The purpose of the proposed study is to examine the impact of thyroid hormone on whi...
What is the current status of trial NCT04098991?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2017-11-08. Estimated completion is 2019-11-08.
What interventions are being tested in trial NCT04098991?
The interventions under investigation include: Levothyroxine (DRUG).
Who is sponsoring clinical trial NCT04098991?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.